| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/30/2006 | CN1824776A Dilatation type cardiomyopathy diagnosis and therapeutic method and reagent used for said method |
| 08/30/2006 | CN1824775A Preparation technology of recombination human blood vessel inhibitor K1-3 and its application in medicine for treating tumour |
| 08/30/2006 | CN1824680A BMP2/7 allodiploid structure analogue, its expression method and application |
| 08/30/2006 | CN1824324A Medicine for repairing and treating viscera injury |
| 08/30/2006 | CN1824316A Liquid used for inhibiting bacterial infection and promoting skin growth |
| 08/30/2006 | CN1824301A Purified ustading and its preparation method and medicinal composition containing said ustading |
| 08/30/2006 | CN1824300A Application of compound MG 132 in preparation of medicine for treating leucocythemia |
| 08/30/2006 | CN1824299A Application of compound PS-341 in preparation of medicine for treating acute pulp leucocythemia |
| 08/30/2006 | CN1824298A Compound medicinal preparation for treating femur necrosis |
| 08/30/2006 | CN1824297A Application of nerve growing factor in preparation of medicine for treating optic nerve affection |
| 08/30/2006 | CN1824296A Use of cone shell polypeptide derivative in preparation of drug abstaining medicine |
| 08/30/2006 | CN1824295A Preparation technology of poly gelatin peptide injection liquid |
| 08/30/2006 | CN1824294A Preparation technology of sarcosine peptide glycoside injection liquid |
| 08/30/2006 | CN1824293A Essential element nutritive preparation for intestine |
| 08/30/2006 | CN1824292A Medicine for improving brain function its preparation method and use |
| 08/30/2006 | CN1824291A Hypersensitivity reaction inhibitor |
| 08/30/2006 | CN1824290A Therapeutic compound joint synovia and its preparation method |
| 08/30/2006 | CN1824289A Use of substance P for mobilization or proliferation of mesenchymal stem cells and for wound healing or accelerating wound healing |
| 08/30/2006 | CN1824288A Application of compound PSI in preparation of medicine for treating leucocythemia |
| 08/30/2006 | CN1824287A Preparation technology of liver hydrolytic peptide injection liquid |
| 08/30/2006 | CN1823983A Medicine for treatign osteopathia, rheumatism and immune disease and its preparation method and use |
| 08/30/2006 | CN1823744A Colloidal suspension of submicronic particles as vectors for active principles and method for preparing same |
| 08/30/2006 | CN1823736A Process to make a sustained release formulation |
| 08/30/2006 | CN1272328C Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 08/30/2006 | CN1272069C Stabilizing medicinal agent containing ciliary nerve nutritive factor analogue |
| 08/30/2006 | CN1272068C Oyster natural active peptide and its preparation method and its application in the preparation of anticancer medicine |
| 08/30/2006 | CN1272067C Application of cyclosporin A in preparing anti-abortion medicine |
| 08/30/2006 | CN1272024C Use of dietary additives for preparing medicament for treating malignancies and viral infections and improving immunologic function |
| 08/29/2006 | US7098375 Animal and cell models for type II diabetes and their use |
| 08/29/2006 | US7098323 Polynucleotide squences and amino acid sequences for diagnosis of diseases and growth factors |
| 08/29/2006 | US7098322 Tumor necrosis factor and proteins with amino acid sequences to modulate signal passageways |
| 08/29/2006 | US7098318 A carboxy terminal peptide fragment of thrombopoietin is fused with the carboxy terminal of human erythropoietin; highly enhanced in vivo half-life due to increased carbohydrate content; no antigenicity |
| 08/29/2006 | US7098316 Isolated nucleic acid, coding regions of genes of proteins, vectors, host cells and genetic engineering for producing proteins and diagnosis of diseaes |
| 08/29/2006 | US7098315 Method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge |
| 08/29/2006 | US7098309 Recombinant hepatitis B surface antigen |
| 08/29/2006 | US7098308 Pentapeptide compounds and uses related thereto |
| 08/29/2006 | US7098307 Neo-tryptophan |
| 08/29/2006 | US7098306 Method and compositions for treating hepatocellular cancer |
| 08/29/2006 | US7098305 Sustained release of microcrystalline peptide suspensions |
| 08/29/2006 | US7098304 Peptides that bind antibodies that are found in elevated levels in body fluids of schizophrenic patients and are found at a lower level or not found at all in body fluids of non-schizophrenic individuals |
| 08/29/2006 | US7098303 Immunogenic polypeptide; vaccine for therapy of HCV infection and assays for the diagnosis of HCV |
| 08/29/2006 | US7098302 Epidermal growth factor receptor; prevention and treatment of disorders associated with overexpression of ErbB2 (e.g., breast cancer). |
| 08/29/2006 | US7098202 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 08/29/2006 | US7098192 Antisense oligonucleotide modulation of STAT3 expression |
| 08/29/2006 | US7098190 Formulations comprising antisense nucleotides to connexins |
| 08/29/2006 | US7098187 for inhibiting endothelial cell proliferation or endothelial tube formation in in vitro or in vivo bioassay |
| 08/29/2006 | US7098186 Depsipeptide compound |
| 08/29/2006 | US7098185 Comprises matrix extracellular phosphoglycoprotein (MEPE) for diagnosing and treating rickets, urogenital, kidney and bone disorders |
| 08/29/2006 | US7098184 Comprises ligand polypeptide for treatment of viral infection and prevention of immunological response; immunosuppressants; genetic vaccines |
| 08/29/2006 | US7098183 cell growth differentiation factors/polypeptides for immunization; animal models |
| 08/29/2006 | US7098029 Product and method for control of obesity |
| 08/29/2006 | US7098026 Human desert hedgehog protein |
| 08/29/2006 | US7098025 Human peroxisome proliferator activated receptor gamma (pparγ) gene regulatory sequences and uses therefor |
| 08/29/2006 | US7098024 Depsipeptide compound |
| 08/29/2006 | US7098015 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor |
| 08/29/2006 | US7098012 DNA demethylase, therapeutic and diagnostic uses thereof |
| 08/29/2006 | US7098006 preparation of an antibody chain having a variable domain comprising three complementarity determining regions |
| 08/29/2006 | US7098004 Isolated polypeptide of the stratum corneum and its use |
| 08/29/2006 | US7097998 Aβ42 lowering agents |
| 08/29/2006 | US7097997 Method for diagnosing a transmissible spongiform subacute encephalyopathy caused by an unconventional transmissible agent strain in a biological sample |
| 08/29/2006 | US7097994 UDP-N-acetylglucosamine:galactose-β1,3-N-acetylgalactosamine-α-R/ (GlcNAc to GaINAc) β1-6 N-acetylglucosaminyltransferase, C2GnT3 |
| 08/29/2006 | US7097992 Uses of human UDP-glucuronosyltransferase 2B7 to detect and treat cancer |
| 08/29/2006 | US7097991 screening for an agent that modulates capsaicin receptor function |
| 08/29/2006 | US7097989 Complement C3 precursor biopolymer markers predictive of type II diabetes |
| 08/29/2006 | US7097987 Hepatitis C receptor protein CD81 |
| 08/29/2006 | US7097985 for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis |
| 08/29/2006 | US7097984 Binding receptors to oocytes; contraceptives |
| 08/29/2006 | US7097982 Peptides and compositions which modulate apoptosis |
| 08/29/2006 | US7097977 Target of anticancer agent |
| 08/29/2006 | US7097972 invention provides non-naturally occurring and isolated naturally occurring nucleic acid molecules which code proteins designated Yama Pro-Yama and non-naturally occurring nucleic acid molecule coding mutant CrmA protein and dominant inhibitory Yama.Vectors and host cells containing these nucleic acids |
| 08/29/2006 | US7097969 IDENTIFYING AN ALLOSTERIC MODULATOR/ANTAGONIST OF G-PROTEIN COUPLED RECEPTORS FOR TREATMENT OF METABOLIC DISORDERS and diseases that have been linked to overactive GPCRs, because traditional neutral-antagonists will not block abnormal ligand-independent activity of these receptors |
| 08/29/2006 | US7097854 Amino alcohol derivatives, process for their production and pharmaceutical preparations and reagents containing these compounds |
| 08/29/2006 | US7097851 Multilayer capsule comprises an adhesion site-controlling layer for attaching to a selected site in the intestines, a drug-carrying layer, a protecting layer for preventing from digestive juice; improve bioavailability due to a low absorption in the digestive tract; dosage forms |
| 08/29/2006 | US7097846 35 kD tumor associated protein antigen: uses and methods of detection |
| 08/29/2006 | US7097845 Combinations of antigen and mucosal binding component for inducing specific immunological tolerance |
| 08/29/2006 | US7097844 T helper cell epitopes |
| 08/29/2006 | US7097841 Ferritin fusion proteins for use in vaccines and other applications |
| 08/29/2006 | US7097839 A conjugated compound contains antibody or a Fab, and a radiostable therapeutic active agent; for diagnosis/therapy of colorectal cancer; biological conjugated drugs |
| 08/29/2006 | US7097838 Antagonists of HMG1 for treating inflammatory conditions |
| 08/29/2006 | US7097837 Synthetic vaccine agents |
| 08/29/2006 | US7097834 Osteoprotegerin binding proteins |
| 08/29/2006 | US7097832 Intramyocardial injection of autologous bone marrow |
| 08/29/2006 | US7097829 Transgenic cells transfected with pituitary tumor transforming gene (PTTG)) expression vectors and uses therefor |
| 08/29/2006 | US7097827 Devices, compositions and methods for the pulmonary delivery of aerosolized medicaments |
| 08/29/2006 | CA2318851C Recombinant human mannan-binding proteins and process for producing the same |
| 08/29/2006 | CA2053585C Antibody production in chinese hamster ovary cells |
| 08/24/2006 | WO2006089290A1 Combinations and modes of administration of therapeutic agents and combination therapy |
| 08/24/2006 | WO2006089226A1 β-BLOCKER PHARMACOGENETICS IN HEART FAILURE |
| 08/24/2006 | WO2006089211A2 Combat/training antioxidant micronutrient formulation and method of administration |
| 08/24/2006 | WO2006089164A1 Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis |
| 08/24/2006 | WO2006089156A2 Drug-polymer conjugates coupled to a peptidic carrier |
| 08/24/2006 | WO2006089150A2 Antiangiogenic agents with aldesleukin |
| 08/24/2006 | WO2006089066A1 Combinations therapy for treatment of demyelinating conditions |
| 08/24/2006 | WO2006089064A1 Methods for treating lymphomas using a combination of a chemotherapeutic agent and il-2 and optionally an anti-cd20 antibody |
| 08/24/2006 | WO2006089062A2 Detection of biomarkers for neuropsychiatric disorders |
| 08/24/2006 | WO2006089023A2 Pharmaceutical compositions for treating or preventing bone conditions |
| 08/24/2006 | WO2006088945A2 Granulysin peptides and methods of use thereof |
| 08/24/2006 | WO2006088906A2 Modulation of muc1 activity |
| 08/24/2006 | WO2006088833A2 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor |
| 08/24/2006 | WO2006088765A1 Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis |